|82.92||+0.31 / +0.38%|
As of 3:59pm ET
|82.91||-0.01 / -0.01%|
The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 103.00, with a high estimate of 125.00 and a low estimate of 77.00. The median estimate represents a +24.22% increase from the last price of 82.92.
The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.